IFNG and neoplasm: Priming MSCs with IFN-γ enhances their antigen-presenting ability by upregulating MHC-I and MHC-II expression.MSCs can deliver anti-neoplastic agents to reduce tumor growth without genetic modification.There are concerns about the unknown effects of the TME on MSCs, as they may be influenced to express more pro-tumorigenic activity.